MiR‐335‐5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2.

MLA

Liu, Ruonan, et al. “MiR‐335‐5p Restores Cisplatin Sensitivity in Ovarian Cancer Cells through Targeting BCL2L2.” Cancer Medicine, vol. 7, no. 9, Sept. 2018, pp. 4598–609. EBSCOhost, https://doi.org/10.1002/cam4.1682.

APA

Liu, R., Guo, H., & Lu, S. (2018). MiR‐335‐5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2. Cancer Medicine, 7(9), 4598–4609. https://doi.org/10.1002/cam4.1682

Chicago

Liu, Ruonan, Hailong Guo, and Shifen Lu. 2018. “MiR‐335‐5p Restores Cisplatin Sensitivity in Ovarian Cancer Cells through Targeting BCL2L2.” Cancer Medicine 7 (9): 4598–4609. doi:10.1002/cam4.1682.